TickerFacts.

A business in context

LONA research notebook

Read the disclosures. Follow the relationships. Keep the dates in view.

Research JSON

Filing timeline

Download filings CSV

SEC submissions · retrieved 2026-09-08 · 8005 issuers; up to 32 recent company reports and 8 ownership-change filings per issuer

  1. 8-K · Current report

    Report date 2026-08-26 · 0001193125-26-368288 · Items 8.01

  2. 10-Q · Quarterly report

    Report date 2026-06-30 · 0001193125-26-352243

  3. 8-K · Current report

    Report date 2026-08-14 · 0001193125-26-352208 · Items 2.02,7.01,9.01

  4. 4 · Ownership change

    Report date 2026-04-09 · 0001193125-26-300876

  5. 4 · Ownership change

    Report date 2026-06-23 · 0001193125-26-299927

  6. 4 · Ownership change

    Report date 2026-06-23 · 0001843393-26-000006

  7. 4 · Ownership change

    Report date 2026-06-23 · 0001790314-26-000004

  8. 4 · Ownership change

    Report date 2026-06-23 · 0001763316-26-000004

  9. 4 · Ownership change

    Report date 2026-06-23 · 0001722055-26-000005

  10. 4 · Ownership change

    Report date 2026-06-23 · 0001679039-26-000003

  11. 4 · Ownership change

    Report date 2026-06-23 · 0001580111-26-000010

  12. 8-K · Current report

    Report date 2026-06-22 · 0001193125-26-279425 · Items 5.07

  13. DEF 14A · Proxy statement

    Report date 2026-06-22 · 0001193125-26-216742

  14. 10-Q · Quarterly report

    Report date 2026-03-31 · 0001193125-26-211898

  15. 8-K · Current report

    Report date 2026-05-07 · 0001193125-26-211867 · Items 2.02,7.01,9.01

  16. 10-K · Annual report

    Report date 2025-12-31 · 0001193125-26-134565

  17. 8-K/A · Current report

    Report date 2025-12-18 · 0001193125-26-134097 · Items 2.01,9.01

  18. 8-K · Current report

    Report date 2026-03-26 · 0001193125-26-126579 · Items 2.02,7.01,9.01

  19. 8-K · Current report

    Report date 2026-03-18 · 0001193125-26-116123 · Items 5.02,5.07,8.01,9.01

  20. DEF 14A · Proxy statement

    Report date 2026-03-18 · 0001193125-26-063952

  21. 8-K · Current report

    Report date 2026-01-07 · 0001193125-26-008904 · Items 5.02,5.03,7.01,8.01,9.01

  22. 8-K/A · Current report

    Report date 2025-12-18 · 0001193125-25-323786 · Items 1.01,3.02,7.01,8.01,9.01

  23. 8-K · Current report

    Report date 2025-12-18 · 0001193125-25-323692 · Items 1.01,3.02,7.01,8.01,9.01

  24. 10-Q · Quarterly report

    Report date 2025-09-30 · 0001193125-25-269544

  25. 8-K · Current report

    Report date 2025-11-06 · 0001193125-25-269506 · Items 2.02,7.01,9.01

  26. 8-K · Current report

    Report date 2025-10-02 · 0001193125-25-229293 · Items 8.01

  27. 8-K · Current report

    Report date 2025-09-10 · 0000950170-25-114093 · Items 3.03,5.03,9.01

  28. 10-Q · Quarterly report

    Report date 2025-06-30 · 0000950170-25-105052

  29. 8-K · Current report

    Report date 2025-08-07 · 0000950170-25-105029 · Items 2.02,7.01,9.01

  30. 8-K · Current report

    Report date 2025-05-29 · 0000950170-25-080234 · Items 5.07

  31. 10-Q · Quarterly report

    Report date 2025-03-31 · 0000950170-25-068040

  32. 8-K · Current report

    Report date 2025-05-09 · 0000950170-25-068020 · Items 2.02,7.01,9.01

  33. 8-K · Current report

    Report date 2025-04-15 · 0000950170-25-054707 · Items 3.01

  34. DEF 14A · Proxy statement

    Report date 2025-05-29 · 0001140361-25-013769

  35. 10-K · Annual report

    Report date 2024-12-31 · 0000950170-25-029069

  36. 8-K · Current report

    Report date 2025-02-27 · 0000950170-25-029038 · Items 2.02,7.01,9.01

  37. SC 13G/A · Ownership disclosure

    0001104659-24-118955

  38. SC 13G · Ownership disclosure

    0001373604-24-000108

  39. 10-Q · Quarterly report

    Report date 2024-09-30 · 0000950170-24-123372

  40. 8-K · Current report

    Report date 2024-11-07 · 0000950170-24-123324 · Items 2.02,7.01,9.01

Reported insider transactions

Download transactions CSV

SEC insider transactions · retrieved 2026-09-07 · 2026 Q2: filings in this completed quarter; not a live transaction feed

Purchases and sales include open-market or private transactions. Grants, exercises and tax withholding are shown separately. Amendments and joint reports can overlap; rows are not a net-buying score. Prices retain the filing's units; consult its footnotes.

Transaction rows by code · counts, not monetary totals
Purchase: 0 transaction rows0PSale: 0 transaction rows0SGrant / award: 24 transaction rows24AExercise / conversion: 0 transaction rows0MTax / exercise payment: 0 transaction rows0FGift: 0 transaction rows0G
P · PurchaseS · SaleA · Grant / awardM · Exercise / conversionF · Tax / exercise paymentG · Gift

24 matching transaction rows.

Transaction / filedReporting ownerTypeSecuritySharesReported price
2026-06-23
2026-06-24
Callori FredA · Grant / award
Acquired
Stock Option (Right to Buy)
Derivative security
2333.00.0
2026-06-23
2026-06-24
Silverman Peter B.A · Grant / award
Acquired
Stock Option (Right to Buy)
Derivative security
2333.00.0
2026-06-23
2026-06-24
Kosacz BarbaraA · Grant / award
Acquired
Stock Option (Right to Buy)
Derivative security
28000.00.0
2026-06-23
2026-06-24
Romano Kelly AA · Grant / award
Acquired
Stock Option (Right to Buy)
Derivative security
28000.00.0
2026-06-23
2026-06-24
Panzara Michael A.A · Grant / award
Acquired
Stock Option (Right to Buy)
Derivative security
28000.00.0
2026-06-23
2026-06-24
Holles Natalie C.A · Grant / award
Acquired
Stock Option (Right to Buy)
Derivative security
2333.00.0
2026-06-23
2026-06-24
PICKERING GRANTA · Grant / award
Acquired
Stock Option (Right to Buy)
Derivative security
28000.00.0
2026-06-23
2026-06-24
JOHNSON JAMES AA · Grant / award
Acquired
Stock Option (Right to Buy)
Derivative security
28000.00.0
2026-06-23
2026-06-24
EDELMAN JOSEPHA · Grant / award
Acquired
Stock Option (Right to Buy)
Derivative security
28000.00.0
2026-05-05
2026-05-07
Callori FredA · Grant / award
Acquired
Stock Option (Right to Buy)
Derivative security
56000.00.0
2026-05-05
2026-05-07
Silverman Peter B.A · Grant / award
Acquired
Stock Option (Right to Buy)
Derivative security
56000.00.0
2026-05-05
2026-05-07
Holles Natalie C.A · Grant / award
Acquired
Stock Option (Right to Buy)
Derivative security
56000.00.0
2026-04-09
2026-04-13
Renninger RobertA · Grant / award
Acquired
Stock Option (Right to Buy)
Derivative security
300000.00.0
2026-04-09
2026-04-13
Worthington MarkA · Grant / award
Acquired
Stock Option (Right to Buy)
Derivative security
300000.00.0
2026-04-09
2026-04-13
CHURCH KEVINA · Grant / award
Acquired
Stock Option (Right to Buy)
Derivative security
300000.00.0
2026-04-09
2026-04-13
San Martin JavierA · Grant / award
Acquired
Stock Option (Right to Buy)
Derivative security
350000.00.0
2026-04-09
2026-04-13
Kosacz BarbaraA · Grant / award
Acquired
Stock Option (Right to Buy)
Derivative security
28000.00.0
2026-04-09
2026-04-13
Romano Kelly AA · Grant / award
Acquired
Stock Option (Right to Buy)
Derivative security
28000.00.0
2026-04-09
2026-04-13
Panzara Michael A.A · Grant / award
Acquired
Stock Option (Right to Buy)
Derivative security
28000.00.0
2026-04-09
2026-04-13
Litton Mark JamesA · Grant / award
Acquired
Stock Option (Right to Buy)
Derivative security
750000.00.0
2026-04-09
2026-04-13
PICKERING GRANTA · Grant / award
Acquired
Stock Option (Right to Buy)
Derivative security
28000.00.0
2026-04-09
2026-04-13
JOHNSON JAMES AA · Grant / award
Acquired
Stock Option (Right to Buy)
Derivative security
28000.00.0
2026-04-09
2026-04-13
FLUKE JOHN M JRA · Grant / award
Acquired
Stock Option (Right to Buy)
Derivative security
28000.00.0
2026-04-09
2026-04-13
EDELMAN JOSEPHA · Grant / award
Acquired
Stock Option (Right to Buy)
Derivative security
28000.00.0

Identity & relationships

Wikidata structured data · retrieved 2026-09-07 · 1611 unambiguous CIK-linked entities; coverage is incomplete

These are sourced identity and relationship claims, with incomplete coverage. Headquarters locations do not describe sales, assets or operating exposure.

SEC issuer · 0001620463LeonaBio, Inc.

No parent relationship is available in this import; this is not proof of independence.

No verified LEI join available.

GLEIF legal entity reference data · retrieved 2026-09-07 · 1177 checked identities; 0 unavailable records

Search names and former names
  • Athira Pharma, Inc. · former SEC name · 2019-09-19 to 2026-01-08
  • M3 Biotechnology, Inc. · former SEC name · 2014-10-03 to 2019-01-23

Revenue in constant purchasing power

USD revenue expressed in 2026-07 consumer-price dollars. Each annual period uses a CPI-U average weighted by the days in its actual reporting interval. This is a purchasing-power comparison, not a company-specific price or volume measure.

No USD annual revenue periods with complete CPI coverage are available. Non-USD statements are not converted with U.S. CPI.

Bureau of Labor Statistics · retrieved 2026-09-08 · 9 selected series; gaps remain missing

Explore the CPI history ↗